We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Inhibition of SUV39H1 reveals potential for effective treatment in multiple myeloma, suggesting a novel approach.
No takes yet. Share an insight, caveat, or question.
Alibert et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: